Glumetza Makers Slapped With 2 New Suits Over Price Hikes
Pharmaceutical companies Bausch Health, Assertio, Salix, Santarus and Lupin now face at least five class actions alleging that they participated in a yearslong scheme that catapulted prices for diabetes drug Glumetza...To view the full article, register now.
Already a subscriber? Click here to view full article